This content is machine translated Chronic inflammatory bowel disease Innovative therapeutic approaches for IBD Last year, the integrin inhibitor or leukocyte migration inhibitor vedolizumab was approved in Switzerland for Crohn’s disease and ulcerative colitis. In addition, biosimilars for infliximab have entered the market. Furthermore,…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
View Post 5 min This content is machine translated Colorectal cancer Why are more and more younger patients becoming ill? There is a significant increase in the incidence of colorectal cancer in the age group below 55 years. In older individuals, diagnoses have been steadily declining for years. Screening recommendations…
View Post 4 min This content is machine translated 2nd Spring Congress of the SGAIM Viral hepatitides – how and whom to test? Hepatitis C is the “favorite child” of current medical ethics discussions. However, the new, expensive HCV drugs should not cloud the view of the overall diagnostic and therapeutic situation of…
View Post 5 min This content is machine translated Liver disease Possibilities of treatment with milk thistle Pharmacological and clinical studies support the efficacy of milk thistle extracts and silymarin – an overview of diseases and efficacy studies.
View Post 2 min This content is machine translated Gastrointestinal stromal tumors (GIST) Is the survival prognosis actually worse for GIST of the small bowel? GIST is most commonly found in the stomach and small intestine. A new comprehensive analysis of the U.S. Surveillance, Epidemiology, and End Results (SEER) database shows that, contrary to popular…
View Post 7 min This content is machine translated Gallbladder diseases What are the surgical options? The most common benign biliary disease, cholecystolithiasis, can cause acute and chronic inflammation of the gallbladder and biliary obstruction. The therapeutic gold standard is laparoscopic cholecystectomy. There are innovative surgical…
View Post 10 min This content is machine translated Colon irritabile (irritable bowel syndrome) Adequate procedure according to IBS subtype Medication and non-drug therapy options are available for irritable bowel syndrome. However, typical symptoms must first be recognized and alarm signs correctly interpreted. A long-term doctor-patient relationship is central to…
View Post 7 min This content is machine translated In-depth: Alternative treatment to proton pump inhibitors. Antacids and alginate in the step-down process and as monotherapy This article expands on the continuing education article “Gastroesophageal reflux disease” on the aspect of alternative treatment for PPI intolerance or discontinuation of the PPI medication. Proton pump inhibitors (PPIs)…
View Post 7 min This content is machine translated In-depth: When proton pump inhibitor (PPI) therapy is not effective. Add-on therapy with alginate This article expands on the continuing education article “Gastroesophageal Reflux Disease” on the aspect of the mode of action of alginate antacid preparations and their role in adjunctive therapy to…
View Post 7 min This content is machine translated Advanced training course in clinical oncology in St. Gallen Metastatic colorectal cancer “beyond surgery”. At the advanced training course in clinical oncology in St. Gallen, there was also a symposium on colorectal carcinoma, among other topics. In an overview, Prof. Dr. med. Ralf-Dieter Hofheinz,…
